Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/65099
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaping, Shunan-
dc.contributor.authorBrowne, Rene Barbie-
dc.contributor.authorVishwakarma, Jai N-
dc.date.accessioned2024-12-24T11:29:12Z-
dc.date.available2024-12-24T11:29:12Z-
dc.date.issued2024-12-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/65099-
dc.description1207-1221en_US
dc.description.abstract5-Methylpyrazolo[1,5-a]pyrimidine derivatives have been synthesized with starting materials that are eithercommercially or easily available. This is achieved by the ultrasonication of 3-amino-1H-pyrazoles (3-7) and enaminones (2) assisted by KHSO4 in aqueous medium. The structures are established by spectral and analytical techniques. An X-ray crystallographic study of compound N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-7-(4-methoxyphenyl)- 5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide (8b) confirms the structural orientation and eliminates any ambiguitypertaining to its regioselectivity. Its space group is P21/n with the following unit cell parameters: a = 17.5775 (8),b = 7.1707 (4), c = 18.113 (1) Å, β = 91.449 (2) and Z = 4. Crystal structure is solved to a final R value of 0.062 and to aGOOF value of 1.09. Molecular docking of the compounds has been executed to identify the potential antiviral andanticancer agents. Moreover, molecular dynamics simulation study of the ligand 9c in a complex with 3pp0, reveals thestability of the potential ligand candidate 9c.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.63(12) [December 2024]en_US
dc.subjectPyrazolo[1,5-a]pyrimidinesen_US
dc.subjectX-ray crystallographyen_US
dc.subjectMolecular dockingen_US
dc.subjectUltrasonicationen_US
dc.titleSynthesis of diversely substituted 5-methylpyrazolo[1,5-a]pyrimidines assisted by ultrasound in aqueous media: Molecular docking for potential antiviral, anticancer activitiesen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/ijc.v63i12.12723en_US
Appears in Collections:IJC Vol.63(12) [December 2024]

Files in This Item:
File Description SizeFormat 
IJC Vol.63(12 ) 1207-1221.pdf1.42 MBAdobe PDFView/Open
IJC Vol.63(12 ) 1207-1221 Suppl. Data.pdf16.92 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.